Behind the Cure

Leading the field of immunology research, CRI supports doctors and scientists working to develop immunotherapy as a cure for all cancers. Join us as we change the way cancer is treated and cured.

Grants and Programs

Be a part of something big: a science-first organization committed to funding the best cancer immunotherapy research done by the best scientists.

CRI Irvington Postdoctoral Fellowships
CRI Irvington Postdoctoral Fellowships

Since its establishment in 1971, CRI has supported more than 1,350 young cancer immunologists at top universities who have deepened our knowledge of the immune system and its relationship to cancer. Postdoctoral fellows, under the guidance of a leading scientist, receive up to $175,500 over three years.

Learn More

Clinic and Laboratory Integration Program (CLIP)
Clinic and Laboratory Integration Program (CLIP)

The development of new and effective cancer treatments requires the translation of basic laboratory discoveries into novel therapies that can be tested in patients. CLIP investigators study critical topics at the intersection of laboratory and clinical research.

Learn More

Lloyd J. Old STAR Program
Lloyd J. Old STAR Program

The Lloyd J. Old STAR Program provides grants of $1.25 million over 5 years to mid-career scientists. This long-term funding will not be tied to a specific research project, but rather will aim to provide a degree of flexibility and freedom for investigators to explore out-of-the-box and disruptive avenues of research.

Learn More

Impact Grants
Impact Grants

Through its Impact Grants, CRI funds projects—often in collaboration with other nonprofits and individual donors—that aim to advance defined scientific and technological goals.

Learn More

Technology Impact Award
Technology Impact Award

The CRI Technology Impact Award provides seed funding of up to $200,000 to be used over 12-24 months to address the gap between technology development and clinical application of cancer immunotherapies.

Learn More

The Clinical Accelerator
The Clinical Accelerator

The Clinical Accelerator brings together the best capabilities of the world's leading academic researchers, drug companies, and a unique nonprofit venture fund to kick-start the development of powerful new treatments for cancer patients.

Learn More

Cancer Immunotherapy Consortium
Cancer Immunotherapy Consortium

A think tank of industry leaders from the cancer immunotherapy space who seek solutions to issues and challenges in late-stage drug development to accelerate patient benefit.

Learn More

Scientific Conferences and Resources

September 14-17, 2020
International Cancer Immunotherapy Conference

The sixth CICON, held in New York City, is devoted to exploring the latest research in cancer immunology and immunotherapy.

Register

Submit
Cancer Immunology Research

Published jointly by CRI and AACR, the academic journal publishes outstanding original research articles reporting major advances in cancer immunology.

Submit Manuscript

Resource
CRI iAtlas

An interactive portal for immuno-oncology research harnessing immunogenomic data from the Cancer Genome Atlas.

Learn More

Explore the Science Behind the Breakthroughs

See How Immunotherapy Works

News & Events

June 27, 2020
CRI Scientist Twitter Takeover
CRI Fellow Dr. Tim Fessenden of MIT shared his day with the CRI social c...
Read Article
June 26, 2020
Immunotherapy Research Helping Confront COVID-19
CRI hosted esteemed immunologists Carl June, Miriam Merad, and E. John Wherry to h...
Read Article
July 20, 2020
Cancer Immunology Symposium
The Symposium will bring together 15 accomplished faculty mentors to share their d...
Read More
June 01, 2020
Eighth Annual Cancer Immunotherapy Month™
30 days of immunotherapy education and awareness programming for patients, caregiv...
Read Release

*Immunotherapy results may vary from patient to patient.

Top